Efficient red-to-NIR photo-uncaging and applications in therapy

NIH RePORTER · NIH · R15 · $406,832 · view on reporter.nih.gov ↗

Abstract

PROJECT SUMMARY Many light-responsive systems have been produced via natural evolution, including opsins, and phytochromes, while chemists have added to the list of light-responsive molecules for new tools. Scientists have embraced the use of these light-responsive tools to construct new materials, and we’ve just scratched the surface of the potential in this important field, particularly in the direction of making efficient red-to-near-infrared (red-to-NIR) light-responsive groups. The promise of red-to-NIR light resides in deeper penetration depth, less scattering and absorption by the sample, and less photodamage. Though approaches that use two-photon and lanthanide nanoparticles exhibit promising progress in allowing red-to-NIR absorption, developing organic-based materials that work under low power LED light is still challenging and such materials would expand the toolboxes and facilitate addressing a number of urgent questions. The organic-based platforms will benefit the fundamental understanding of chemical structure-to-property relationships, as well as impact many intriguing emerging applications, such as precision drug delivery, neuron modulation, light-triggered reactions, and gene therapy activation. Because of the much lower photon energy in the red-to-NIR region compared with UV and blue light, efficient red-to-NIR responsive is still challenging. This proposal aims to develop novel boron-dipyrromethene (BODIPY) based photo-uncaging groups that build upon weak covalent N-O bond. In particular, the weak dissociation energy of N-O permits the cleavage after absorbing low energy red-to-NIR photon, which is ideal for biological and biomedical applications. By varying and modifying the chemical structures, we intend to increase photo-uncaging efficiency by rigidifying the structure and for the first time facilitate dual cargo release from BODIPY. After conjugating with a cancer targeting unit, biomedical applications of these novel photo-uncaging materials will be demonstrated in vitro and in vivo in light-triggered drug delivery. Overall, the capability of efficient photo-uncaging in the red-to-NIR window will support more advanced experimental designs, and the convergence of basic research with applications will contribute to expanding knowledge while benefiting undergraduate researchers for broad impact.

Key facts

NIH application ID
10794730
Project number
1R15EB034477-01A1
Recipient
NEW JERSEY INSTITUTE OF TECHNOLOGY
Principal Investigator
Yuanwei Zhang
Activity code
R15
Funding institute
NIH
Fiscal year
2024
Award amount
$406,832
Award type
1
Project period
2024-08-08 → 2026-07-31